KCNH2 encodes a nuclear-targeted polypeptide that mediates hERG1 channel gating and expression
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2214700120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Abhilasha Jain und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109. Hauptthemen laut MEDLINE: ERG1 Potassium Channel, Ether-A-Go-Go Potassium Channels, Myocytes, Cardiac. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
KCNH2 encodes hERG1, the voltage-gated potassium channel that conducts the rapid delayed rectifier potassium current (I Kr ) in human cardiac tissue. hERG1 is one of the first channels expressed during early cardiac development, and its dysfunction is associated with intrauterine fetal death, sudden infant death syndrome, cardiac arrhythmia, and sudden cardiac death. Here, we identified a hERG1 polypeptide (hERG1 NP ) that is targeted to the nuclei of immature cardiac cells, including human stem cell-derived cardiomyocytes (hiPSC-CMs) and neonatal rat cardiomyocytes. The nuclear hERG1 NP immunofluorescent signal is diminished in matured hiPSC-CMs and absent from adult rat cardiomyocytes. Antibodies targeting distinct hERG1 channel epitopes demonstrated that the hERG1 NP signal maps to the hERG1 distal C-terminal domain. KCNH2 deletion using CRISPR simultaneously abolished I Kr and the hERG1 NP signal in hiPSC-CMs. We then identified a putative nuclear localization sequence (NLS) within the distal hERG1 C-terminus, 883-RQRKRKLSFR-892. Interestingly, the distal C-terminal domain was targeted almost exclusively to the nuclei when overexpressed HEK293 cells. Conversely, deleting the NLS from the distal peptide abolished nuclear targeting. Similarly, blocking α or β1 karyopherin activity diminished nuclear targeting. Finally, overexpressing the putative hERG1 NP peptide in the nuclei of HEK cells significantly reduced hERG1a current density, compared to cells expressing the NLS-deficient hERG1 NP or GFP. These data identify a developmentally regulated polypeptide encoded by KCNH2 , hERG1 NP , whose presence in the nucleus indirectly modulates hERG1 current magnitude and kinetics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109.
- University of Texas at San Antonio, San Antonio, TX 78249.
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109.
ORCID-Profile: Olivia Stack, Francisco G Sanchez-Conde, David K Jones
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute
- HHS | NIH | National Institute of General Medical Sciences
Zitieren
APA
Jain, A., Stack, O., Ghodrati, S., Sanchez-Conde, F. G., Ukachukwu, C. U., Salwi, S., Jimenez-Vazquez, E. N., & Jones, D. K. (2023). KCNH2 encodes a nuclear-targeted polypeptide that mediates hERG1 channel gating and expression. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2214700120
Vancouver
Jain A, Stack O, Ghodrati S, Sanchez-Conde FG, Ukachukwu CU, Salwi S, et al. KCNH2 encodes a nuclear-targeted polypeptide that mediates hERG1 channel gating and expression. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2214700120
BibTeX
@article{Jain2023,
author = {Jain, Abhilasha and Stack, Olivia and Ghodrati, Saba and Sanchez-Conde, Francisco G and Ukachukwu, Chiamaka U and Salwi, Shreya and Jimenez-Vazquez, Eric N and Jones, David K},
title = {KCNH2 encodes a nuclear-targeted polypeptide that mediates hERG1 channel gating and expression},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2214700120}
}
EUVIMED